Revance Therapeutics Inc
NASDAQ:RVNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Revance Therapeutics Inc
NASDAQ:RVNC
|
US |
|
Volvo AB
OTC:VLVLY
|
SE |
|
BBMG Corp
SSE:601992
|
CN |
|
D
|
DVS Technology AG
F:DIS
|
DE |
|
Perenti Global Ltd
ASX:PRN
|
AU |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
Cogent Communications Holdings Inc
NASDAQ:CCOI
|
US |
|
Everspin Technologies Inc
NASDAQ:MRAM
|
US |
|
Fsn E-Commerce Ventures Ltd
NSE:NYKAA
|
IN |
|
Sword Group SE
PAR:SWP
|
LU |
|
Pebble Group PLC
LSE:PEBB
|
UK |
|
I
|
Illinois Tool Works Inc
XBER:ILT
|
US |
Shareholder Yield
Current shareholder yield for RVNC is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RVNC Price
Revance Therapeutics Inc
| Average Annual Return | -27.07% |
| Standard Deviation of Annual Returns | 30.39% |
| Max Drawdown | -94% |
| Market Capitalization | 382.9m USD |
| Shares Outstanding | 104 390 000 |
| Percentage of Shares Shorted | 4.96% |
